CTLA-4 and PD-1/ PD-L1 immune checkpoint inhibitors in extensive stage small cell lung cancer
Small cell lung cancer (SCLC) is a highly aggressive malignancy with rapid disease progression, easy recurrence in the short term and extremely poor prognosis. SCLC is recognized as a refractory disease by the National Cancer Institute. In recent years, immunotherapy has made breakthrough progress i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
The Editorial Department of Chinese Journal of Clinical Research
2023-06-01
|
| Series: | Zhongguo linchuang yanjiu |
| Subjects: | |
| Online Access: | http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20230602 |